Poland· PL-100451515
Ipidacrine hydrochloride Grindeks
A anticholinesterases product containing ipidacrini hydrochloridum monohydricum, registered in Poland by AS Grindeks. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ipidacrini hydrochloridum monohydricum is registered in 2 of 19 countries.
Countries holding a registration under ATC N07AA (anticholinesterases), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Ipidacrini hydrochloridum monohydricum · ATC N07AA
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Ipidacrini hydrochloridum monohydricum
- Manufacturer
- AS Grindeks
- Country
- Poland (PL)
- ATC code
- N07AA
- ATC class
- Anticholinesterases
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04750232019191
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ipidacrini hydrochloridum monohydricum in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46ab2865-4db8-447d-a707-0122c41fcb95 GET /v1/drugs/46ab2865-4db8-447d-a707-0122c41fcb95?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "15 mg/ml",
"packaging": "04750232019191 ¦ Rp ¦ 147925\n10 amp. 1 ml",
"substance": "Ipidacrini hydrochloridum monohydricum 16.2 mg/ml",
"common_name": "Ipidacrini hydrochloridum monohydricum",
"pl_product_id": "100451515",
"pozwolenie_nr": "27460",
"auth_procedure": "DCP",
"authorisation_validity": "2027-11-09"
}See everything about ipidacrini hydrochloridum monohydricum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.